**Background of GKAP Antibodies**
GKAP (G-protein kinase A-anchoring protein), also known as SAPAP (synapse-associated protein-associated protein), is a scaffolding protein enriched in the postsynaptic density (PSD) of neuronal synapses. It plays a critical role in organizing the molecular architecture of excitatory synapses by linking glutamate receptors (e.g., NMDA receptors) to downstream signaling molecules and cytoskeletal elements. GKAP interacts with PSD-95. a major PSD scaffold protein, and connects it to Shank family proteins, forming a core complex essential for synaptic stability and plasticity.
Antibodies targeting GKAP are vital tools in neuroscience research, enabling the detection and localization of GKAP in brain tissues or cultured neurons. These antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), and immunoprecipitation to study synaptic protein networks, synaptic development, and dysfunction in neurological disorders. Alterations in GKAP expression or interactions have been implicated in neurodevelopmental and psychiatric conditions, including autism spectrum disorders (ASD), schizophrenia, and Alzheimer’s disease.
By probing GKAP’s distribution and protein-protein interactions, researchers gain insights into synaptic signaling pathways, mechanisms of synaptic plasticity (e.g., long-term potentiation), and disease-associated synaptic deficits. GKAP antibodies thus serve as key reagents for unraveling the molecular basis of brain function and pathology.